Codexis

Company CDXS

Last mentioned: 4h ago

Stories mentioning Codexis 2

pharma Neutral

Wall Street Zen Upgrades Codexis and Enovis on Strong 2026 Growth Outlooks

Wall Street Zen has upgraded the stock ratings for Codexis (CDXS) and Enovis (ENOV), signaling increased confidence in their long-term strategic pivots. The upgrades follow robust quarterly performances and the unveiling of ambitious 2026 revenue targets driven by high-margin technological innovations.

2 sources
pharma Bullish

Biotech Sector Pivots: Codexis, Elutia, and Biote Signal Strategic Shifts

Q4 2025 earnings for specialized biotech firms reveal a sector-wide shift toward high-margin manufacturing and strategic divestitures. While Codexis capitalizes on its Merck partnership and ECOsynthesis platform, Elutia has cleared its debt through an $88 million divestiture to Boston Scientific.

9 sources